Ingredient

Alogliptin Benzoate

Alogliptin benzoate is a blood glucose control ingredient used in the treatment of type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
5
Single ingredient
2
Combination
3
Prescription medication
5

MFDS ingredient code M115650

What does it do?

Alogliptin benzoate belongs to the DPP-4 inhibitor class of diabetes treatment ingredients. This ingredient helps promote insulin secretion and lower blood glucose levels. It is primarily used in medications for blood glucose control in patients with type 2 diabetes.

Alogliptin benzoate inhibits the DPP-4 enzyme in the body, preventing the degradation of incretin hormones. This results in increased insulin secretion and effective blood glucose control. Additionally, it also demonstrates the ability to suppress blood glucose elevation.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Alogliptin benzoate has superior blood glucose control effects compared to other DPP-4 inhibitors while having fewer side effects. It is often used in combination with metformin, which can be expected to yield a synergistic effect.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

5 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.